In this paper, we reviewed the mechanisms and potential drugs of insulin signaling pathway in the treatment of T2DM complicated with HF to provide a comprehensive and detailed reference for relevant studies, and to contribute to the further research and development of new drugs for T2DM patients with HF. This evidence concerns the gene INS and hydrops fetalis.